Connect with us

Technology

Linus Health to Demonstrate How Digital Health Powers Innovation at Clinical Trials on Alzheimer’s Disease (CTAD)

Published

on

Leaders to deliver four poster presentations showing how its digital health platform lowers investigator burden, enables precision recruitment, and delivers best-in-class outcomes assessments for streamlined and meaningful clinical trials

MADRID, Oct. 29, 2024 /PRNewswire/ — Clinical and research leaders from Linus Health, a digital health company enabling early detection of Alzheimer’s and other dementias, will deliver four poster presentations at a pre-eminent international conference on Alzheimer’s disease taking place this week.

Linus Health leaders will present their findings at the 17th annual Clinical Trials on Alzheimer’s Disease (CTAD) conference, which runs today through this Friday, Nov. 1, in Madrid, Spain. The conference is expected to attract 2,200 leading experts onsite and online to discuss the latest therapeutic advances in Alzheimer’s disease. Scientists from across the globe will present clinical trial results and new therapeutic strategies to treat people experiencing all stages of the disease, as well as the latest on Alzheimer’s prevention.

Posters from Linus Health and other researchers will be on display for in-person viewing on Nov. 1 from 7:15 a.m. to 5 p.m. Central European Time (6 hours ahead of Eastern Standard Time). All posters are also accessible via the CTAD24 digital platform.

“It is a privilege to be invited to present four poster presentations at such a prestigious conference that attracts a large, global audience,” said Linus Health CEO David Bates, PhD. “This honor certainly demonstrates the quality and relevancy of our research. It is also an indicator that the leaders in the field of Alzheimer’s disease and related dementias recognize the growing value of augmenting human clinical expertise with innovative technology to deliver much broader insight into cognitive function with greater efficiency.”

Linus Health poster presentations include:

“Streamlining Recruitment for AD Clinical Trials: Concurrent Detection of Cognitive Impairment and Amyloid-Beta PET Status with a Machine Learning Enabled Digital Cognitive Assessment.” Findings from Director of Cognitive Science Linus Health Ali Jannati, MD, PhD, show that the accuracy of Linus Health’s Digital Clock and Recall™ (DCR™) platform matched blood-based biomarkers in predicting cognitive impairment and were superior or comparable to traditional cognitive tests. The results demonstrate that the DCR effectively streamlines recruitment for clinical trials, offers a cost-effective solution for selecting suitable participants, and reduces screen failure rates.”Incorporating personally defined brain health priorities in clinical trials outcomes: the electronic Person Specific Outcome Measure approach in the U.S.” This study by Chief Medical Officer Alvaro Pascual-Leone, MD, PhD, found heterogeneity in individual-level brain health priorities in the United States. The findings indicate that self-reported confidence in managing personally meaningful priorities may be an appropriate construct to incorporate the person’s voice in study outcomes. They also suggest that Linus Health’s electronic Person Specific Outcome Measure tool supports the establishment of clinical meaningfulness in Alzheimer’s disease trials and is now being validated in other global populations.”Identification of Cognitive Impairment in Alzheimer’s Disease with Drawing and Speech-Based Assessments and Metrics.” The poster from Data Scientist Tanya Talkar, PhD, showcases the benefits of combining speech- and linguistic-based metrics with drawing- and process-based metrics in screening for cognitive impairment. Since the screening can be administered both in the clinic and remotely, it offers researchers accessible, repeated recordings to screen for clinical trials or evaluation of disease-modifying therapies.”Digital Assessment of Cognition for Optimizing Neuropsychology Workflow.” Jannati is presenting another study he led that proposes a workflow involving a technology-enabled psychometry assistant (TPA), a medical assistant equipped with the Linus Health Core Cognitive Evaluation (CCE) and Clinical Decision Support (CDS) system, to streamline the initial cognitive assessment process at the primary care level. The proposed workflow significantly improved the efficiency of neuropsychological evaluations by reducing the workload of specialists, avoiding unnecessary referrals, and prioritizing those that need further assessment.

The 17th annual CTAD conference will take place at the Madrid Marriott Auditorium Hotel and Conference Center, and via the CTAD virtual platform.

To learn more about Linus Health’s research and solutions for clinical trials, or to take a closer look at our platform’s suite of digital assessments, click here

About Linus Health
Linus Health is a Boston-based digital health company focused on transforming brain health for people across the world. By advancing how we detect and address cognitive and brain disorders – leveraging cutting-edge neuroscience, clinical expertise, and artificial intelligence – our goal is to enable a future where people can live longer, happier and healthier lives with better brain health. Linus Health’s digital cognitive assessment platform delivers a proven, practical means of enabling early detection; empowers providers with actionable clinical insights; and supports individuals with personalized action plans. We are proud to partner with leading healthcare delivery organizations, research institutions and life sciences companies to accelerate more proactive intervention and personalized care in brain health. To learn more about our practical solutions for proactive brain health, visit www.linushealth.com or follow us on LinkedIn.

Media Contact
Tara Stultz
Amendola for Linus Health
440-225-9595
tstultz@acmarketingpr.com 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/linus-health-to-demonstrate-how-digital-health-powers-innovation-at-clinical-trials-on-alzheimers-disease-ctad-302289415.html

SOURCE Linus Health

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

ResumeTemplates.com Survey Reveals 3 in 10 Gen Zers Believe CEOs Are Evil; Many Support Release of Mangione

Published

on

By

The majority of Gen Zers feel CEOs wield excessive power, with some expressing extreme views about corporate accountability

SEATTLE, Dec. 27, 2024 /PRNewswire-PRWeb/ — ResumeTemplates.com, the leading platform for professional resume templates and career advice, has released findings from a recent survey revealing critical attitudes among Gen Z toward corporate leaders. Conducted in December 2024, the survey of 1,200 U.S.-based Gen Zers highlights the sentiment that CEOs hold excessive power and are overcompensated, with some respondents expressing extreme views about corporate accountability.

According to the survey, more than half of Gen Zers (55%) believe CEOs wield excessive power in society, particularly influencing elections, the economy, and policymaking. Additionally, 59% of respondents believe CEOs are overpaid, with most saying total annual compensation should not exceed $750,000. Only 7% of respondents support unlimited earning potential for CEOs. The survey also found that 39% of Gen Zers believe all levels of a workforce equally contribute to a company’s success, while only 20% think CEOs create the most value within an organization.

The survey also explored Gen Z’s perceptions of corporate leadership. More than half believe CEOs are responsible for driving corporate greed, and 30% of respondents view CEOs as “evil,” reflecting deep skepticism toward corporate leadership.

Additionally, the survey examined opinions on high-profile cases like Brian Thompson’s killing. Among respondents, 21% agreed that “CEOs deserve to lose their lives for their professional actions,” including 7% who strongly agreed. When asked specifically about Brian Thompson’s killing, 22% of respondents believe he definitely (10%) or probably (12%) deserved what happened to him. Regarding Luigi Mangione, Thompson’s accused killer, 21% supported his release, while 51% opposed it.

This survey, conducted December 18, 2024, via Pollfish, gathered responses from 1,200 U.S.-based 18 to 27 year olds. The full report can be viewed here: https://www.resumetemplates.com/3-in-10-gen-zers-say-ceos-are-evil-many-believe-mangione-should-go-free/

ABOUT RESUMETEMPLATES.COM
ResumeTemplates.com offers a comprehensive selection of free, industry-specific resume templates, tailored to meet the needs of various job seekers. The website also provides extensive resources to help facilitate the job application process, including expert advice, resume examples, and tips and tricks for creating impactful resumes. For more information, please visit: https://www.resumetemplates.com/.

Media Contact

Abigail Davis, ResumeTemplates, 000-0000, abigail@resumetemplates.com

View original content:https://www.prweb.com/releases/resumetemplatescom-survey-reveals-3-in-10-gen-zers-believe-ceos-are-evil-many-support-release-of-mangione-302338434.html

SOURCE ResumeTemplates

Continue Reading

Technology

Founder Shares Unforgettable Lessons After Spending $1 Million on a Domain Name

Published

on

By

ATLANTA, Dec. 27, 2024 /PRNewswire/ — VPN.com CEO Michael Gargiulo recently shared invaluable insights with Entrepreneur on the unforgettable lessons he learned while spending $1 million to acquire the premium domain VPN.com.

Gargiulo’s journey to acquiring VPN.com wasn’t just about landing a high-value web address. In the Entrepreneur.com article titled “5 Unforgettable Lessons I Learned Spending $1 Million on a Domain Name”, Gargiulo emphasizes the long-term value a premium domain brings to brand trust, visibility, and scalability.

Investing in a Domain: More Than Just a Name

Gargiulo’s $1 million purchase of VPN.com was more than a simple transaction—it was an investment in the future of his business and the value of owning a recognizable, exact-match domain. “The right domain can change everything for a brand. It immediately creates trust and credibility with customers, and it sets your company apart from the competition,” said Gargiulo.

In the article, he shares five critical lessons learned during his experience, including the importance of patience, timing, and the negotiating power of a premium domain. “A domain isn’t just a digital asset—it’s a business strategy. Acquiring VPN.com helped us stand out in the crowded cybersecurity market and continues to drive our success.”

Brand Trust and Global Recognition

Since acquiring VPN.com, Gargiulo has expanded his company’s mission to help hundreds of millions of people secure a private internet experience. The premium domain has played a pivotal role in building trust with customers, partners, and investors. “A premium domain acts as an instant signal of authority,” Gargiulo noted. “It makes a lasting impression, and in today’s fast-moving digital world, that’s invaluable.”

A Vision for the Future

Gargiulo’s vision for VPN.com extends beyond the domain. With a mission to provide a secure internet experience for one billion people by 2030, VPN.com is at the forefront of internet privacy, security, and premium domain brokerage. Gargiulo’s experience acquiring VPN.com has equipped him with unique insights into the premium domain marketplace, helping businesses recognize the value of digital branding in today’s world.

Read More About Michael Gargiulo’s Insights

To read Gargiulo’s full breakdown of the lessons learned from his $1 million domain purchase, visit the Entrepreneur article here.

In addition, Gargiulo also contributed to the Entrepreneur article “Getting a Divorce With a Six-Figure Domain Portfolio”, where he shares insights on the unique challenges of managing and valuing a high-profile domain portfolio in complex personal and financial situations.

For media inquiries or interviews, please contact:

Michael Gargiulo
855-VPN-FAST
388102@email4pr.com

Visit: vpn.com for more information.

About VPN.com
VPN.com is a global leader in internet security and premium domain brokerage, dedicated to helping entrepreneurs, businesses, and individuals protect their brands and secure their online presence. With a $1 million domain name and a mission to serve one billion people by 2030, VPN.com is at the cutting edge of internet privacy, security, and digital branding.

Learn more about VPN.com’s work:

Michael Gargiulo Shares Insider Secrets on Premium Domain ValuationHow to Acquire a Premium Domain Via Stealth AcquisitionVPN.com Renews Commitment to Freedom, Digital Liberties, and Brand Protection

For more insights on digital brand protection and domain name acquisition, visit: vpn.com/domains.

View original content:https://www.prnewswire.com/news-releases/founder-shares-unforgettable-lessons-after-spending-1-million-on-a-domain-name-302339666.html

SOURCE VPN.com

Continue Reading

Technology

OCR Canada Rebrands to Levata

Published

on

By

TORONTO, Dec. 27, 2024 /CNW/ — OCR Canada Ltd., Canada’s leading solutions provider of automated identification data capture (AIDC) products, software, and services for businesses across industries and government organizations, is pleased to announce its rebrand to Levata as of January 1, 2025. This transition unites Canada’s operations with Levata’s global identity, streamlining the company’s messaging while honoring OCR Canada’s more than 40-year legacy of trusted service and expertise.

The name OCR, which originally stood for Optical Character Recognition, reflects a technology that no longer represents the company’s comprehensive offerings. Rebranding to Levata supports the broader strategic vision of uniting Levata across markets under one multinational brand to better communicate the full value Levata delivers to its customers.

“This rebrand is an exciting milestone for Canada,” said Tony Mastrangeli, Executive Vice President & GM of Canada. “While our name is changing, the exceptional service, expertise, and relationships our customers rely on remain the same. Levata will continue to empower businesses with tailored solutions, just as OCR Canada has for more than 40 years.”

The transition follows a successful history of growth in Canada, with OCR Canada joining Levata in 2014. Since then, the Canadian arm has expanded its expertise through strategic acquisitions and established itself as a leading provider of AIDC solutions across industries.

“This rebrand marks the next step in Levata’s long-term vision,” said Dan Nettesheim, CEO of Levata. “By uniting under a single, global identity, we are amplifying our global message that we enable our customers to elevate their potential. Today, we provide solutions beyond OCR and barcoding, we also offer leading technology and services for enterprise mobility, RFID, networking, IT infrastructure, and more to help customers succeed in a competitive and rapidly evolving market.”

To complement this transformation, Levata Canada will launch a French-enabled eCommerce platform in January 2025, further enhancing customer access and experience.

For more information about the rebranding, visit www.Levata.com/en-ca/news/ocr-canada-rebrands-to-levata.

About Levata
Levata enables customers to elevate their potential by providing strategies, solutions, and services that power modern environments. With a broad suite of technology products to enable enterprise mobility, a digital supply chain, a secure workplace, and an elevated customer experience, and the services to move businesses forward, Levata unlocks the power of thousands of organizations worldwide. Levata has operated as a market leader in full-stack technology solutions for over 40 years. Learn more at www.levata.com.

Alana Tufford, Director, Enterprise Marketing
Levata
905-475-5505 x242
branding@levata.com

SOURCE Levata

Continue Reading

Trending